Biological and Pharmaceutical Bulletin
The Pharmaceutical Society of Japan, established in 1880, is one of Japan’s oldest and most distinguished academic societies. The Society currently has around 18,000 members. It publishes three monthly scientific journals. Chemical and Pharmaceutical Bulletin (Chem. Pharm. Bull.) began publication in 1953 as Pharmaceutical Bulletin. It covers chemistry fields in the pharmaceutical and health sciences. Biological and Pharmaceutical Bulletin (Biol. Pharm. Bull.) began publication in 1978 as the Journal of Pharmacobio-Dynamics. It covers various biological topics in the pharmaceutical and health sciences. A fourth Society journal, the Journal of Health Science, was merged with Biol. Pharm. Bull. in 2012. Yakugaku Zasshi (Japanese for “Pharmaceutical Science Journal”) has the longest history, with publication beginning in 1881. Yakugaku Zasshi is published mostly in Japanese, except for some articles related to clinical pharmacy and pharmaceutical education, which are published in English.
The main aim of the Society’s journals is to advance the pharmaceutical sciences with research reports, information exchange, and high-quality discussion. The average review time for articles submitted to the journals is around one month for first decision. The complete texts of all of the Society’s journals can be freely accessed through J-STAGE. The Society’s editorial committee hopes that the content of its journals will be useful to your research, and also invites you to submit your own work to the journals.

Chairman of Committee
Ken-ichi Hosoya
Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama

Read more
9,354 registered articles
(updated on January 20, 2018)
Online ISSN : 1347-5215
Print ISSN : 0918-6158
Featured article
Volume 40 (2017) Issue 12 Pages 2158-2165
Evaluation of Drug-Induced Photosensitivity Using the Japanese Adverse Drug Event Report (JADER) Database Read more
Editor’s picks

Drug-induced photosensitivity (DIP) is a cutaneous adverse event caused by the combined effects of a medication and exposure to light. The article by Nakao et al.  evaluated the association between drugs and DIP by using the reporting odds ratio and time-to-onset analysis data from the Japanese Adverse Drug Event Report (JADER) database. More than half of the reports of DIP onset following ketoprofen administration were recorded within 10 days of initiation of treatment. The seasonal variation of DIP was shown to follow an annual sinusoidal pattern with peaks observed in April and May. The results of this study suggest close monitoring of patients taking suspected drugs, especially during the peak season of photosensitivity reactions.

View the past featured articles
View all articles in Current issue
Most viewed articles Dec.2017
Share this page
Select past volume & issue
Journal news & Announcements
  • Biol. Pharm. Bull. Vol. 40 No. 12
    Current Topics: Recent Progress in the Study of Vasoactive Modulators in Metabolic and Cardiovascular Diseases